Botulinum Toxin Market report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and industry challenges.
The global botulinum toxin market is projected to observe substantial growth owing to the rising demand for cosmetic non-invasive processes across the world. In addition, the increasing use of the product to treat eye disorders like uncontrolled blinking (blepharospasm), and crossed eyes (strabismus) is likely to increase its demand over the coming years. additionally, the rising use of botulinum toxin for the treatment of excessive drooling/saliva and underarm sweating is also likely to augment industry size.
According to a research report by GMI Inc., the botulinum toxin market is likely to surpass a valuation of $8.9 billion by 2026.
Request for a sample copy of this report @ https://www.decresearch.com/request-sample/detail/3408
Botulinum toxin A is extensively used to treat square jaws, crow’s fee and forehead lines and wrinkles. The product is also used in easing cases of chronic pelvic pain in women with endometriosis. It is also experiencing high adoption for treating muscle spasm. Multiple therapeutic indications of botulinum toxin will boost the product demand over the coming years. In 2019, botulinum toxin A segment dominated the global market in and is set to grow at to 8.9% CAGR over 2020-2026.
Aesthetic surgeries using botulinum toxin show long-lasting results with fewer side effects. Aesthetic applications accounted for 42.4% of the botulinum toxin market share. Increasing preference of patient for aesthetic surgeries which are technologically advanced and carried out under safety parameters may bolster product demand in future.
Industry revenues from the spa & cosmetic centers are estimated to showcase significant growth rate of 9.2% through 2026. The growth can be attributed to rise in number of cosmetic surgeries performed annually across the globe along with technological advancement in cosmetology which is driving the demand for botulinum toxin products. Moreover, other benefits offered by these centers like de-stressing and relaxation may contribute to the consumption of the chemical.
APAC botulinum toxin market share will garner significant gains through 2026 on account of rising disposable incomes, high growth rate of aging population and associated demand for facial cosmetic treatments. Botulinum toxin products are witnessing high demand in the region due to rising product awareness along with accessibility to new technologies. Moreover, there is rise in number of aesthetic surgeries with the availability of trained plastic surgeons in region.
Some of the established botulinum toxin providers are Eisai Co., Ltd., Revance Therapeutics, Inc, Hugel Inc., Galderma S.A., Hugh source international ltd., Allergan, Medytox Inc., Merz Pharma and Ipsen, among others.
Browse full table of contents (TOC) of this report @ https://www.decresearch.com/toc/detail/botulinum-toxin-market
Partial Chapter of the Table of Content
Chapter 4. Botulinum Toxin Market, By Product
4.1. Key segment trends
4.2. Botulinum Toxin A
4.2.1. Market size, by region, 2015 - 2026 (USD Million)
4.3. Botulinum Toxin B
4.3.1. Market size, by region, 2015 - 2026 (USD Million)
Chapter 5. Botulinum Toxin Market, By Application
5.1. Key segment trends
5.2.1. Market size, by region, 2015 - 2026 (USD Million)
5.3.1. Market size, by region, 2015 - 2026 (USD Million)